|
FENC Fennec Pharmaceuticals Inc 1211583 |
| Balance Sheet |
|
Current Assets
|
$66,880,000.00 |
|
Assets
|
$71,822,000.00 |
|
Current Liabilities
|
$9,586,000.00 |
|
Liabilities
|
$34,147,000.00 |
|
Equity
|
$37,675,000.00 |
|
Shares Out
|
34541000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$2,379,000.00 |
| Market Analysis |
Market Cap
|
$342,301,310.00 |
|
Price
|
$9.47 |
|
BVPS
|
1.09 |
|
PB
|
9.09 |
|
EPS
|
0.01 |
|
PS
|
15.54 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:29 |
|
| Apr |
May |
Jun |
| 2026-03-24 |
-0.17 |
|
|
2026-05-14 |
0.01 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.11 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.02 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FENC documents filed with the SEC.
FENC Filings
Clear
